Bicara Therapeutics Inc. Balance Sheet
BCAX / Health Care|2 years of annual SEC 10-K data (FY2023-FY2024)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 2 fiscal years. All figures from audited SEC 10-K filings.
Bicara Therapeutics Inc. had $510M in total assets and $492M in shareholders' equity as of FY2024.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 11.58 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 |
|---|---|---|
| Cash & Equivalents | $489.7M | $230.4M |
| Current Assets | $502.5M | $231.1M |
| PP&E (Net) | $155.0K | $202.0K |
| Total Assets | $510.0M | $234.0M |
| Current Liabilities | $18.0M | $15.1M |
| Shareholders' Equity | $491.9M | -$148.8M |